Udenafil CAS 268203-93-6

Udenafil is the fourth in a class of drugs targeting the inhibition of the enzyme phosphodiesterase 5 (PDE5) for the treatment of erectile dysfunction. Inhibition of PDE5 results in the increase in endogenous cyclic guanosine monophosphate (cGMP) concentrations in the penile corpus cavernosum. cGMP induces smooth muscle cell relaxation and subsequent increased blood flow leading to a sustainable erection. Udenafil is a potent antagonist of human PDE5 with an IC₅₀ of 8.25nM and a comparable selectivity profile as sildenafil for the other PDEs. Unlike tadalafil, it does not inhibit PDE11, which has been implicated in myalgia and testicular toxicity. Furthermore, udenafil produced up to a 91% vaginal penetration success rate and up to a 67% intercourse completion rate compared to a 29% completion rate by placebo. Overall patient satisfaction, measured by a standard global assessment question, was 86% compared to only 26% in the placebo group. The most frequently recorded adverse events were mild-to-moderate facial flushing and headache.

Udenafil is an inhibitor of phosphodiesterase 5 (PDE5). In vivo, udenafil (1 and 5 mg/kg) increases lung cGMP levels, attenuates the development of compensatory right ventricular hypertrophy, and reduces pulmonary arterial wall thickening in a rat model of monocrotaline-induced pulmonary hypertension. It increases creatine clearance and decreases blood urea nitrogen (BUN) and serum malondialdehyde (MDA) levels in a rat model of renal ischemia-reperfusion injury. Udenafil (0.3 and 10 mg/kg) induces penile erections in conscious rabbits and in rabbits with acute spinal cord injury.

Me gelek kargehên kalîteya bilind bi hevkariyek kûr heye, ku dikarin ji we re hilberên kalîteya bilind û bihayên reqabetê peyda bikin. Û em dikarin ji bo kirînên mezin erzanan jî bidin. Û em bi gelek pargîdaniyên barkêş ên profesyonel re hevkariyê dikin, dikarin hilberan bi ewlehî û bi aramî radestî destên we bikin. Dema radestkirinê piştî pejirandina dravdanê 3-20 rojan e.

Product Name:	Udenafil
Synonyms:	5-[2-propyloxy-5-(2-(1-Methylpyrrolidin-2-yl)ethylaMinosulphonyl)phenyl]-1-Methyl-3-propyl-6,7-dihydro-1H-pyrazolo(4,3-d)pyriMidin-7-one;5-[2-propyloxy-5-[2-(1-Methyl-2-pyrrolidinyl)ethylaMinosulfonyl]phenyl]-1-Methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyriMidine-7-one;Zydena;Udenafil(DA 8159,Zydena);BenzenesulfonaMide,3-(6,7-dihydro-1-Methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-N-[2-(1-Methyl-2-pyrrolidinyl)ethyl]-4-propoxy-;Udenafil, DA 8159;CS-1353;Udenafil, >=98%
CAS:	268203-93-6
MF:	C25H36N6O4S
MW:	516.66
EINECS:	251-228-4
Product Categories:	Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:	268203-93-6.mol

1. Ma hûn kargehek an pargîdaniyek bazirganî ne?
Em pargîdaniyek in ku pîşesazî û bazirganiyê entegre dike, karûbarê yek-stop peyda dike. OEM dikare were pejirandin.

2. Ma hûn nimûne pêşkêş dikin? Ew belaş an zêde ye?
Nimûneyên belaş. Pêdivî ye ku heqê barkirina nimûneyê ji hêla we ve were dayîn.

3. Hûn belgeyên ku bi kontrola kalîteyê ve girêdayî ne?
Sertîfîkaya ISO 9001: 2008 ji bo misogerkirina kalîteyê.

4. Divê ez çi peyda bikim da ku jêderkek bistînim?
Ji kerema xwe celebê hilberê ku hûn hewce ne, hêjmara fermanê, navnîşan û hewcedariyên taybetî me agahdar bikin. Dê di wextê de ji bo referansa we veqetandin were çêkirin.

5. Hûn rêbazek dravdanê çawa tercîh dikin? Mercên çawa têne qebûl kirin?
Mercên Radestkirina Pejirandî: FOB, CFR, CIF, EXW;
Pereyê Tezmînata Qebûlkirî:USD;
Tîpa dravdana pejirandî: T/T, Yekîtiya Rojavayî; Paypal, Ewlekariya Bazirganî.
Zimanê axaftinê: Îngilîzî.